Hui Feng

COO, Shanghai Junshi Biosciences Company Limited


Hui Feng is the COO of Shanghai Junshi Biosciences Company Limited, mainly responsible for the daily operations and management of Junshi Group. Dr. Feng also works as an executive director and legal representative of Junshi Biotechnology and the legal representative, executive director and general manager of Suzhou Junmeng. Dr. Feng took part in the invention of a number of registered patents and patents in application to JS001, JS002 and JS003 for Junshi Group.

Dr. Feng has over 10 years of industry experience in biotechnology and drug discovery. His experience spans multiple areas of drug development including antibody discovery, protein engineering and Immuno-oncology. Dr. Feng was a postdoc scholar at Albert Einstein College of Medicine and served as a production manager at HumanZyme Inc. and as a scientist at MedImmune, Inc. (a subsidiary of AstraZeneca).

Dr. Feng obtained his Bachelor’s degree in biological science and technology from Tsinghua University in China in July 1997 and his Ph.D. degree in molecular pharmacology from Albert Einstein College of Medicine in the US  in September 2003. He has published academic articles and invented a number of patents.